SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-159684
Filing Date
2020-06-03
Accepted
2020-06-03 17:14:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d830403d424b5.htm 424B5 845576
2 GRAPHIC g830403g57j37.jpg GRAPHIC 33539
  Complete submission text file 0001193125-20-159684.txt   892792
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-227814 | Film No.: 20940920
SIC: 2835 In Vitro & In Vivo Diagnostic Substances